François Maltais
- Effectiveness of exercise training in patients with COPD: the role of muscle fatigueBy Chris Burtin, Didier Saey, Melda Saglam, Daniel Langer, Rik Gosselink, Wim Janssens, Marc Decramer, François Maltais and Thierry TroostersChris Burtin*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium+These authors contributed equally to the manuscriptDidier Saey¶Centre de recherche de l' Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université, Laval, Quebec, QC, Canada+These authors contributed equally to the manuscriptMelda Saglam#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, BelgiumDaniel Langer*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, BelgiumRik Gosselink*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, BelgiumWim Janssens#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, BelgiumMarc Decramer#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, BelgiumFrançois Maltais¶Centre de recherche de l' Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université, Laval, Quebec, QC, CanadaThierry Troosters*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
- Repeatability and responsiveness of exercise tests in pulmonary arterial hypertensionBy Vincent Mainguy, Simon Malenfant, Anne-Sophie Neyron, Sébastien Bonnet, François Maltais, Didier Saey and Steeve ProvencherVincent MainguyPulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CanadaSimon MalenfantPulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CanadaAnne-Sophie NeyronPulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CanadaSébastien BonnetPulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CanadaFrançois MaltaisPulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CanadaDidier SaeyPulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CanadaSteeve ProvencherPulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, Canada
- Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPDBy François Maltais, Donald A. Mahler, Véronique Pepin, Eric Nadreau, Glenn D. Crater, Andrea N. Morris, Amanda H. Emmett and Thomas J. FerroFrançois Maltais1Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QCDonald A. Mahler2Geisel School of Medicine at Dartmouth, Hanover, NHVéronique Pepin3Centre de Recherche, Hôpital du Sacré-Coeur de Montréal, Montréal, QCEric Nadreau1Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QCGlenn D. Crater4GlaxoSmithKline, Mississauga, ON, CanadaAndrea N. Morris5GlaxoSmithKline, Research Triangle Park, NC, USAAmanda H. Emmett5GlaxoSmithKline, Research Triangle Park, NC, USAThomas J. Ferro5GlaxoSmithKline, Research Triangle Park, NC, USA
- What are the factors related to misdiagnosis of COPD?By Jean Bourbeau, Denis O'Donnell, Francois Maltais, Darcy Marciniuk, Andrea Benedetti, Shawn Aaron, Ken Chapman, Robert Cowie, Mark Fitzgerald, Paul Hernandez, Don Sin and Wan TanJean Bourbeau1Medicine, McGill University, Montreal, QC, Canada; {Don}{D.}{SinDenis O'Donnell2Medicine, Queens University, Kingston, ON, CanadaFrancois Maltais3Medicine, Universite Laval, Quebec, QC, CanadaDarcy Marciniuk4Medicine, University of Saskatchewan, Saskatoon, SK, CanadaAndrea Benedetti1Medicine, McGill University, Montreal, QC, Canada; {Don}{D.}{SinShawn Aaron5Medicine, Ottawa University, Ottawa, ON, CanadaKen Chapman6Medicine, University of Toronto, Toronto, ON, CanadaRobert Cowie8Medicine, University of Toronto, Toronto, ON, CanadaMark Fitzgerald7Medicine, University of Calgary, Calgary, AB, CanadaPaul Hernandez10Medicine, University of British Columbia, Vancouver, BC, CanadaDon Sin10Medicine, University of British Columbia, Vancouver, BC, CanadaWan Tan10Medicine, University of British Columbia, Vancouver, BC, Canada
- Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation, in COPDBy Marc Decramer, Francois Maltais, Gregory Feldman, Jean Brooks, Lisa Willits, Stephanie Harris and Glenn CraterMarc Decramer1Respiratory Division, University Hospital, University of Leuven, Leuven, BelgiumFrancois Maltais2Institut Universitaire de Cardiologie et de Pneumologie, Faculté de Médecine, Université Laval, Laval, CanadaGregory Feldman3Research, S. Carolina Pharmaceutical, Spartanburg, United StatesJean Brooks4Respiratory Medicines Development Centre, GlaxoSmithKline, Uxbridge, United KingdomLisa Willits5Respiratory Medicines Development Centre S&P, GlaxoSmithKline, Uxbridge, United KingdomStephanie Harris6Medicines Development Centre, GlaxoSmithKline, Rearch Triangle Park, United StatesGlenn Crater7Respiratory and Immuno-Inflammation Medicine Development Center, GlaxoSmithKline, Rearch Triangle Park, United States
- Home-based rehabilitation program for lung cancer patientsBy Valérie Coats, François Maltais, Sébastien Simard, Έric Fréchette and Didier SaeyValérie CoatsPneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, CanadaFrançois MaltaisPneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, CanadaSébastien SimardPneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, CanadaΈric FréchettePneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, CanadaDidier SaeyPneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, Canada
- Efficacy and safety of AZD3199, an inhaled ultra long-acting β2-agonist, in patients with COPDBy Piotr Kuna, Yavor Ivanov, Vasily Trofimov, Ola Beckman, Thomas Bengtsson, Carin Jorup and Francois MaltaisPiotr Kuna1Autonomous Public Healthcare Unit, Barlicki University Hospital, Lodz, PolandYavor Ivanov2Dept of Pulmonology, Medical University Pleven, Pleven, BulgariaVasily Trofimov3Department of Hospital Therapy, Pavlov State Medical University, St. Petersburg, Russian FederationOla Beckman4Research and Development, AstraZeneca R&D, Lund, SwedenThomas Bengtsson4Research and Development, AstraZeneca R&D, Lund, SwedenCarin Jorup4Research and Development, AstraZeneca R&D, Lund, SwedenFrancois Maltais5Centre de Pneumologie, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, Canada
- Lower limb fatigue, during walking in patients with COPDBy Philippe Gagnon, Valérie Coats, Laurent Bouyer, Cynthia Brouillard, François Maltais and Didier SaeyPhilippe Gagnon1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, QC, CanadaValérie Coats1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, QC, CanadaLaurent Bouyer2Centre de Recherche, Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale, Quebec, QC, CanadaCynthia Brouillard1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, QC, CanadaFrançois Maltais1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, QC, CanadaDidier Saey1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, QC, Canada
- The effect of tiotropium on lung dynamic hyperinflation and treadmill exercise capacity in mild to moderate COPDBy Richard Casaburi, Francois Maltais, Janos Porszasz, Frank Albers, Qiqi Deng, Ahmar Iqbal, Heather Paden and Denis O'DonnellRichard Casaburi1Division of Respiratory and Critical Care Physiology and Medicine, Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesFrancois Maltais2Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec, CanadaJanos Porszasz1Division of Respiratory and Critical Care Physiology and Medicine, Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesFrank Albers3Medical Affairs Respiratory, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United StatesQiqi Deng3Medical Affairs Respiratory, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United StatesAhmar Iqbal4Respiratory Medical Affairs, Pfizer Inc, New York, NY, United StatesHeather Paden3Medical Affairs Respiratory, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United StatesDenis O'Donnell5Department of Medicine, Queen's University & Kingston General Hospital, Kingston, ON, Canada
- COPD severity and health impact across the current CanCOLD populationBy Jean Bourbeau, Wan C. Tan, Andrea Benedetti, Shawn D. Aaron, Kenneth R. Chapman, Harvey Cookson, Robert Cowie, J. Mark Fitzgerald, Roger Goldstein, Paul Hernandez, Jonathon Leipsic, Francois Maltais, Darcy Marciniuk, Denis O'Donnell and Donald D. SinJean Bourbeau1Medicine, McGill University, Montréal, QC, CanadaWan C. Tan1Medicine, McGill University, Montréal, QC, CanadaAndrea Benedetti1Medicine, McGill University, Montréal, QC, CanadaShawn D. Aaron1Medicine, McGill University, Montréal, QC, CanadaKenneth R. Chapman1Medicine, McGill University, Montréal, QC, CanadaHarvey Cookson1Medicine, McGill University, Montréal, QC, CanadaRobert Cowie1Medicine, McGill University, Montréal, QC, CanadaJ. Mark Fitzgerald1Medicine, McGill University, Montréal, QC, CanadaRoger Goldstein1Medicine, McGill University, Montréal, QC, CanadaPaul Hernandez1Medicine, McGill University, Montréal, QC, CanadaJonathon Leipsic1Medicine, McGill University, Montréal, QC, CanadaFrancois Maltais1Medicine, McGill University, Montréal, QC, CanadaDarcy Marciniuk1Medicine, McGill University, Montréal, QC, CanadaDenis O'Donnell1Medicine, McGill University, Montréal, QC, CanadaDonald D. Sin1Medicine, McGill University, Montréal, QC, Canada
- Improvement in exercise capacity in obese obstructive sleep apnea (OSA): Respective impact of ventilatory support during exercise and respiratory muscle training in a randomized controlled trialBy Isabelle Vivodtzev, Renaud Tamisier, Marilie Croteau, Jean-Christophe Rambert, Angélique Grangier, Sandy Gorain, Jean-Christian Borel, Bernard Wuyam, Patrick Lévy, Caroline Minville, Frédéric Sériès, François Maltais and Jean-Louis PépinIsabelle Vivodtzev1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FranceRenaud Tamisier1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FranceMarilie Croteau2Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie Du Québec, Québec, QC, CanadaJean-Christophe Rambert1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FranceAngélique Grangier1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FranceSandy Gorain1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FranceJean-Christian Borel1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FranceBernard Wuyam1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FrancePatrick Lévy1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, FranceCaroline Minville2Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie Du Québec, Québec, QC, CanadaFrédéric Sériès2Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie Du Québec, Québec, QC, CanadaFrançois Maltais2Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie Du Québec, Québec, QC, CanadaJean-Louis Pépin1Univ Grenoble Alps, HP2 Laboratory, Inserm U1042, Grenoble University Hospital, EFCR and Locomotion, Reeducation and Physiology, Grenoble, France
- Body composition analysis using computed tomography image in patients with advanced lung cancerBy Valerie Coats, Jean-Simon Lalancette, Fernanda Ribeiro, Yves Lacasse, Lise Tremblay, François Maltais and Didier SaeyValerie Coats1Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, CanadaJean-Simon Lalancette1Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, CanadaFernanda Ribeiro1Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, CanadaYves Lacasse1Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, Canada3Medicine, Faculty De Medicine, Université Laval, Québec, CanadaLise Tremblay1Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, Canada3Medicine, Faculty De Medicine, Université Laval, Québec, CanadaFrançois Maltais1Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, Canada3Medicine, Faculty De Medicine, Université Laval, Québec, CanadaDidier Saey1Research Center, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, Canada2Rehabilitation, Faculty of Medicine, Université Laval, Québec, Canada
- Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD studyBy Laura Labonté, Palmina Mancino, Wan Tan, Robert Cowie, Paul Hernandez, Kenneth R. Chapman, Pei Z. Li, Shawn Aaron, Andrea Benedetti, Mark Fitzgerald, François Maltais, Darcy Marciniuk, Denis O'Donnell, Don Sin and Jean BourbeauLaura Labonté1Medicine, McGill University, Montreal, QC, CanadaPalmina Mancino1Medicine, McGill University, Montreal, QC, CanadaWan Tan2Medicine, University of British Columbia, Vancouver, CanadaRobert Cowie3Medicine, University of Calgary, Calgary, CanadaPaul Hernandez4Medicine, Dalhousie University, Halifax, CanadaKenneth R. Chapman5Medicine, University of Toronto, Toronto, CanadaPei Z. Li1Medicine, McGill University, Montreal, QC, CanadaShawn Aaron6Medicine, Ottawa University, Ottawa, CanadaAndrea Benedetti1Medicine, McGill University, Montreal, QC, CanadaMark Fitzgerald2Medicine, University of British Columbia, Vancouver, CanadaFrançois Maltais7Medicine, Université Laval, Québec, CanadaDarcy Marciniuk8Medicine, University of Saskatchewan, Saskatoon, CanadaDenis O'Donnell9Medicine, Queens University, Kingston, CanadaDon Sin2Medicine, University of British Columbia, Vancouver, CanadaJean Bourbeau1Medicine, McGill University, Montreal, QC, Canada
- Reproducibility of metabolic parameters measured during endurance shuttle walking test in patients with COPDBy Benoit Borel, Véronique Pépin, Donald A. Mahler, Eric Nadreau, Glenn D. Crater, Andrea N. Morris, Amanda H. Emmett, Thomas J. Ferro and François MaltaisBenoit Borel1Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Quebec, QC, CanadaVéronique Pépin2Centre De Recherche, Hôpital Du Sacre-Coeur De Montréal, Montreal, QC, CanadaDonald A. Mahler3Geisel School of Medicine, Darmouth Institute for Health Policy and Clinical Practice, Hanover, NH, United StatesEric Nadreau1Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Quebec, QC, CanadaGlenn D. Crater4GSK, GlaxoSmithKline, Mississauga, ON, CanadaAndrea N. Morris5GSK, GlaxoSmithKline, Research Triangle Park, NC, United StatesAmanda H. Emmett5GSK, GlaxoSmithKline, Research Triangle Park, NC, United StatesThomas J. Ferro5GSK, GlaxoSmithKline, Research Triangle Park, NC, United StatesFrançois Maltais1Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Quebec, QC, Canada
- Comparison of gender-related risk factors for COPD - Results from the Canadian obstructive lung disease (CanCOLD) studyBy Wan Tan, Denis O'Donnell, Shawn Aaron, Darcy Marciniuk, J. Mark Fitzgerald, Robert Cowie, Kenneth Chapman, Paul Hernandez, Don Sin, Francois Maltais and Jean BourbeauWan Tan1UBC James Hogg Research Center, St Paul's Hosp, University of British Columbia, Vancouver, BC, CanadaDenis O'Donnell2Division of Respiratory & Critical Care Medicine, Queen's University, Kingston, ON, CanadaShawn Aaron3Ottawa Hospital Research Institute, University of Ottawa, Ottawa, CanadaDarcy Marciniuk4Division of Respirology, University of Saskatchewan, Saskatoon, CanadaJ. Mark Fitzgerald5Department of Respiratory Medicine, University of British Columbia, Vancouver, CanadaRobert Cowie6Department of Medicine and Community Health Sciences, University of Calgary, Calgary, CanadaKenneth Chapman7Asthma & Airway Center, University of Toronto, Toronto, CanadaPaul Hernandez8Respiratory Division, Dalhousie University, Halifax, CanadaDon Sin1UBC James Hogg Research Center, St Paul's Hosp, University of British Columbia, Vancouver, BC, CanadaFrancois Maltais9Centre De Pneumologie, Laval University, Quebec City, CanadaJean Bourbeau10Respiratory Epidemiology and Clinical Research Unit, Mcgill University, Montreal, Canada
- Effects of a combination of vilanterol and umeclidinium on exercise endurance in subjects with COPD: Two randomised clinical trialsBy Francois Maltais, Sally Singh, Alison Donald, Alison Church, Glenn Crater, Aik Goh and John RileyFrancois Maltais1Centre De Pneumologie, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, CanadaSally Singh2Cardiac and Pulmonary Rehabilitation, Glenfield Hospital, Leicester, United KingdomAlison Donald3Medicines Development, GlaxoSmithKline, Research Triangle Park, NC, United StatesAlison Church3Medicines Development, GlaxoSmithKline, Research Triangle Park, NC, United StatesGlenn Crater4Medicines Development, GlaxoSmithKline, Mississauga, ON, CanadaAik Goh5Medicines Development, GlaxoSmithKline, Uxbridge, United KingdomJohn Riley5Medicines Development, GlaxoSmithKline, Uxbridge, United Kingdom
- Repeatability and responsiveness of exercise tests in pulmonary arterial hypertensionBy Vincent Mainguy, Simon Malenfant, Anne-Sophie Neyron, Sébastien Bonnet, François Maltais, Didier Saey and Steeve ProvencherArticle | Published in 2012 in European Respiratory JournalVincent Mainguy*Pulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CANADASimon Malenfant*Pulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CANADAAnne-Sophie Neyron*Pulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CANADASébastien Bonnet*Pulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CANADAFrançois Maltais*Pulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CANADADidier Saey*Pulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CANADASteeve Provencher*Pulmonary Hypertension Research Group, Centre de recherche de l'Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, CANADA
- Utility scores in patients with oxygen-dependent COPD: A case-control studyBy Yves Lacasse, Sarah Bernard and François MaltaisYves Lacasse1Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, QC, CanadaSarah Bernard1Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, QC, CanadaFrançois Maltais1Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Québec, QC, Canada
- Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1&2 COPDBy Janos Porszasz, Shuyi Ma, Robert Cao, Ashwani Gore, William Phillips, Rachel Cooper, François Maltais, Gary T. Ferguson, Denis E. O'Donnell, Heather Paden and Richard CasaburiJanos Porszasz1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesShuyi Ma2Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, United StatesRobert Cao1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesAshwani Gore1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesWilliam Phillips1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesRachel Cooper1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesFrançois Maltais3Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Université Laval, Québec, CanadaGary T. Ferguson4Pulmonary Research, Pulmonary Research Institute of Southeast Michigan, Livonia, MI, United StatesDenis E. O'Donnell5Department of Medicine, Queen's University & Kingston General Hospital, Kingston, ON, CanadaHeather Paden6Clinical Trial Management, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United StatesRichard Casaburi1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States
- Prospective validation of the endurance shuttle walking test in the context of bronchodilation in COPDBy Benoit Borel, Véronique Pepin, Donald A. Mahler, Éric Nadreau and François MaltaisArticle | Published in 2014 in European Respiratory JournalBenoit Borel1Centre de recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval, Quebec, Canada2Laboratoire HAVAE (EA6310), Université de Limoges, Limoges, FranceVéronique Pepin3Centre de recherche, Hôpital du Sacré-Coeur de Montréal, Montreal, CanadaDonald A. Mahler4Geisel School of Medicine at Dartmouth, Hanover, NH, USAÉric Nadreau1Centre de recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval, Quebec, CanadaFrançois Maltais1Centre de recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval, Quebec, Canada
- Prospective validation of the endurance shuttle walking test in the context of bronchodilation in COPDBy Benoit Borel, Véronique Pepin, Donald A. Mahler, Éric Nadreau and François MaltaisBenoit Borel1Centre de recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval, Quebec, Canada2Laboratoire HAVAE (EA6310), Université de Limoges, Limoges, FranceVéronique Pepin3Centre de recherche, Hôpital du Sacré-Coeur de Montréal, Montreal, CanadaDonald A. Mahler4Geisel School of Medicine at Dartmouth, Hanover, NH, USAÉric Nadreau1Centre de recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval, Quebec, CanadaFrançois Maltais1Centre de recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec – Université Laval, Quebec, Canada
- Effects of 12 weeks of once-daily tiotropium and olodaterol fixed-dose combination on exercise endurance in patients with COPDBy François Maltais, Juan Bautista Gáldiz Iturri, Anne Kirsten, Dave Singh, Alan Hamilton, Kay Tetzlaff, Yihua Zhao and Richard CasaburiFrançois Maltais1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaJuan Bautista Gáldiz Iturri2Respiratory Function, BioCruces Health Research Institute, Barakaldo, SpainAnne Kirsten3Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center, Grosshansdorf, GermanyDave Singh4Medicines Evaluation Unit, University of Manchester, Manchester, United KingdomAlan Hamilton5Medical, Boehringer Ingelheim, Burlington, CanadaKay Tetzlaff6Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany9Dept of Sports Medicine, Medical Clinic V, University of Tübingen, Tübingen, GermanyYihua Zhao7Biostatistics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield,Richard Casaburi8Los Angeles BioMedical Research Institute, Harbor-UCLA Medical Center, Los Angeles,
- Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studiesBy Roland Buhl, Eric Derom, Gary Ferguson, François Maltais, Emilio Pizzichini, Jim Reid, Henrik Watz, Lars Groenke, Alan Hamilton, Kay Tetzlaff, Lawrence Korducki, Holger Huisman, Stella Waitere-Wijker and Eric BatemanRoland Buhl1Pulmonary Department, Mainz University Hospital, Mainz, GermanyEric Derom2Respiratory Division, Ghent University Hospital, Ghent, BelgiumGary Ferguson3Pulmonology Department, Pulmonary Research Institute of Southeast Michigan, Livonia,François Maltais4Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaEmilio Pizzichini5NUPAIVA (Asthma Research Centre), Universidade Federal de Santa Catarina, Santa Catarina, BrazilJim Reid6Dunedin School of Medicine, University of Otago, Dunedin, New ZealandHenrik Watz7Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North, Grosshansdorf, GermanyLars Groenke8Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyAlan Hamilton9Medical, Boehringer Ingelheim, Burlington, CanadaKay Tetzlaff8Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany10Dept of Sports Medicine, Medical Clinic V, University of Tübingen, Tübingen, GermanyLawrence Korducki11Biostatistics, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield,Holger Huisman12Medical, Boehringer Ingelheim B.V., Alkmaar, NetherlandsStella Waitere-Wijker12Medical, Boehringer Ingelheim B.V., Alkmaar, NetherlandsEric Bateman13Division of Pulmonology, University of Cape Town Lung Institute, Cape Town, South Africa
- Late-breaking abstract: Cluster analysis of objectively measured physical activity in 1001 COPD patientsBy Rafael Mesquita, Gabriele Spina, Fabio Pitta, David Donaire-Gonzalez, Brenda M. Deering, Mehul S. Patel, Katy E. Mitchell, Jennifer Alison, Arnoldus J. R. van Gestel, Stefanie Zogg, Philippe Gagnon, Beatriz Abascal-Bolado, Barbara Vagaggini, Judith Garcia-Aymerich, Sue C. Jenkins, Elisabeth A. P. M. Romme, Samantha S.C. Kon, Paul S. Albert, Benjamin Waschki, Dinesh Shrikrishna, Sally J. Singh, Nicholas S. Hopkinson, David Miedinger, Roberto P. Benzo, François Maltais, Pierluigi Paggiaro, Zoe J. McKeough, Michael I. Polkey, Kylie Hill, William D-C. Man, Christian F. Clarenbach, Nidia A. Hernandes, Daniela Savi, Sally Wootton, Karina C. Furlanetto, Li W. Cindy Ng, Anouk W. Vaes, Christine Jenkins, Peter R. Eastwood, Diana Jarreta, Anne Kirsten, Dina Brooks, David R. Hillman, Thaís Sant'Anna, Kenneth Meijer, Selina Dürr, Malcolm Kohler, Vanessa S. Probst, Ruth Tal-Singer, Esther Garcia Gil, Jörg D. Leuppi, Peter M.A. Calverley, Frank W. J. M. Smeenk, Richard W. Costello, Marco Gramm, Roger Goldstein, Miriam Groenen, Helgo Magnussen, Emiel F.M. Wouters, Richard L. ZuWallack, Oliver Amft, Henrik Watz and Martijn A. SpruitRafael Mesquita1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, Netherlands2Department of Respiratory Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, NetherlandsGabriele Spina3Department of Signal Processing Systems, Technische Universiteit Eindhoven, Eindhoven, Netherlands4Smart Sensing and Analysis Group, Philips Research, Eindhoven, NetherlandsFabio Pitta5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilDavid Donaire-Gonzalez6Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainBrenda M. Deering7Department of Respiratory Medicine, Beaumont Hospital, Dublin, IrelandMehul S. Patel8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomKaty E. Mitchell9NIHR EM CLAHRC - Centre for Exercsie and Rehabilitation Science, University Hospitals, Leicester, United KingdomJennifer Alison10Clinical and Rehabilitation Sciences, The University of Sydney, Sydney, NSW, Australia11Physiotherapy Department, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaArnoldus J. R. van Gestel12Pulmonary Division, University Hospital of Zurich, Zurich, SwitzerlandStefanie Zogg13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandPhilippe Gagnon14Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, CanadaBeatriz Abascal-Bolado15Division of Pulmonary, Hospital U. Marqués de Valdecilla, IFIMAV, Santander, Spain16Mindful Breathing Laboratory, Mayo Clinic, Rochester, MN,Barbara Vagaggini17Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyJudith Garcia-Aymerich6Centre for Research in Environmental Epidemiology (CREAL), Barcelona, SpainSue C. Jenkins18School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, AustraliaElisabeth A. P. M. Romme19Department of Respiratory Medicine, Catharina Hospital, Eindhoven, NetherlandsSamantha S.C. Kon8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomPaul S. Albert20School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, United KingdomBenjamin Waschki21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyDinesh Shrikrishna8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomSally J. Singh9NIHR EM CLAHRC - Centre for Exercsie and Rehabilitation Science, University Hospitals, Leicester, United KingdomNicholas S. Hopkinson8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomDavid Miedinger13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandRoberto P. Benzo16Mindful Breathing Laboratory, Mayo Clinic, Rochester, MN,François Maltais14Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, CanadaPierluigi Paggiaro17Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, ItalyZoe J. McKeough10Clinical and Rehabilitation Sciences, The University of Sydney, Sydney, NSW, AustraliaMichael I. Polkey8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomKylie Hill18School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, AustraliaWilliam D-C. Man8NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomChristian F. Clarenbach12Pulmonary Division, University Hospital of Zurich, Zurich, SwitzerlandNidia A. Hernandes5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilDaniela Savi22Department of Pediatrics and Pediatric Neurology, Cystic Fibrosis Center, Sapienza University of Rome, Rome, ItalySally Wootton10Clinical and Rehabilitation Sciences, The University of Sydney, Sydney, NSW, AustraliaKarina C. Furlanetto5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilLi W. Cindy Ng18School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, AustraliaAnouk W. Vaes1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, NetherlandsChristine Jenkins23Woolcock Institute of Medical Research, The University of Sydney, Camperdown, NSW, AustraliaPeter R. Eastwood24Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Perth, WA, AustraliaDiana Jarreta25R&D Centre, Almirall, Barcelona, SpainAnne Kirsten21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyDina Brooks26Respiratory Medicine, West Park Healthcare Centre, Toronto, CanadaDavid R. Hillman24Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Perth, WA, AustraliaThaís Sant'Anna5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, BrazilKenneth Meijer27Department of Human Movement Science, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, NetherlandsSelina Dürr13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandMalcolm Kohler12Pulmonary Division, University Hospital of Zurich, Zurich, SwitzerlandVanessa S. Probst5Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, Brazil28Centro de Pesquisa em Ciências da Saúde, Centro de Ciências Biológicas e da Saúde, Universidade Norte do Paraná (UNOPAR), Londrina, Paraná, BrazilRuth Tal-Singer29GlaxoSmithKline, King of Prussia, PA,Esther Garcia Gil25R&D Centre, Almirall, Barcelona, SpainJörg D. Leuppi13Medical University Clinic, Cantonal Hospital Baselland, Liestal and Medical Faculty, University of Basel, Basel, SwitzerlandPeter M.A. Calverley20School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, United KingdomFrank W. J. M. Smeenk19Department of Respiratory Medicine, Catharina Hospital, Eindhoven, NetherlandsRichard W. Costello7Department of Respiratory Medicine, Beaumont Hospital, Dublin, IrelandMarco Gramm21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyRoger Goldstein26Respiratory Medicine, West Park Healthcare Centre, Toronto, CanadaMiriam Groenen1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, NetherlandsHelgo Magnussen21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyEmiel F.M. Wouters1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, Netherlands2Department of Respiratory Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, NetherlandsRichard L. ZuWallack30Department of Pulmonary and Critical Care, Saint Francis Hospital and Medical Center, Hartford, CT,Oliver Amft3Department of Signal Processing Systems, Technische Universiteit Eindhoven, Eindhoven, Netherlands31ACTLab Group, Chair of Sensor Technology, University Passau, Passau, GermanyHenrik Watz21Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Center North, Member of the German Centre for Lung Research, Grosshansdorf, GermanyMartijn A. Spruit1Department of Research & Education, Center of Expertise for Chronic Organ Failure+ (CIRO+), Horn, Netherlands32REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium
- Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) studyBy Laura Labonté, Palmina Mancino, Wan Tan, Robert Cowie, Paul Hernandez, Kenneth Chapman, Pei Li, Shawn Aaron, Andrea Benedetti, Mark Fitzgerald, François Maltais, Darcy Marciniuk, Denis O'Donnell, Don Sin and Jean BourbeauLaura Labonté1Medicine, McGill University, Montreal, CanadaPalmina Mancino1Medicine, McGill University, Montreal, CanadaWan Tan2Medicine, University of British Columbia, Vancouver, CanadaRobert Cowie3Medicine, University of Calgary, Calgary, CanadaPaul Hernandez4Medicine, Dalhousie University, Halifax, CanadaKenneth Chapman5Medicine, University of Toronto, Toronto, CanadaPei Li1Medicine, McGill University, Montreal, CanadaShawn Aaron6Medicine, University of Ottawa, Ottawa, CanadaAndrea Benedetti1Medicine, McGill University, Montreal, CanadaMark Fitzgerald2Medicine, University of British Columbia, Vancouver, CanadaFrançois Maltais7Medicine, Laval University, Québec, CanadaDarcy Marciniuk8Medicine, University of Saskatchewan, Saskatchewan, CanadaDenis O'Donnell9Medicine, Queens University, Kingston, CanadaDon Sin2Medicine, University of British Columbia, Vancouver, CanadaJean Bourbeau1Medicine, McGill University, Montreal, Canada
- Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)By Roland Buhl, François Maltais, Roger Abrahams, Leif Bjermer, Eric Derom, Gary Ferguson, Matjaž Fležar, Jacques Hébert, Lorcan McGarvey, Emilio Pizzichini, Jim Reid, Antony Veale, Lars Grönke, Alan Hamilton, Lawrence Korducki, Kay Tetzlaff, Stella Waitere-Wijker, Henrik Watz and Eric BatemanArticle | Published in 2015 in European Respiratory JournalRoland Buhl1Pulmonary Department, Mainz University Hospital, Mainz, GermanyFrançois Maltais2Département de Médecine, Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaRoger Abrahams3Department of Clinical Research, Morgantown Pulmonary Associates, Morgantown, WV, USALeif Bjermer4Department of Respiratory Medicine and Allergology, Lund University, Lund, SwedenEric Derom5Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumGary Ferguson6Pulmonary Research Institute of Southeast Michigan, Livonia, MI, USAMatjaž Fležar7Klinika Golnik, Golnik, SloveniaJacques Hébert8Department of Medicine, Centre de Recherche Appliquée en Allergie de Québec (CRAAQ), Québec, CanadaLorcan McGarvey9Department of Medicine, Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UKEmilio Pizzichini10Department of Pulmonology, NUPAIVA (Asthma Research Centre), Universidade Federal de Santa Catarina, Santa Catarina, BrazilJim Reid11Dunedin School of Medicine, University of Otago, Dunedin, New ZealandAntony Veale12Department of Respiratory Medicine, The Queen Elizabeth Hospital, Adelaide, AustraliaLars Grönke13Department of Medical Affairs Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyAlan Hamilton14Medical Department, Boehringer Ingelheim, Burlington, Ontario, CanadaLawrence Korducki15Department of Biostatistics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAKay Tetzlaff13Department of Medical Affairs Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany16Department of Sports Medicine, Medical Clinic V, University of Tübingen, Tübingen, GermanyStella Waitere-Wijker17Medical Department, Boehringer Ingelheim B.V., Alkmaar, The NetherlandsHenrik Watz18Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research, Grosshansdorf, GermanyEric Bateman19Division of Pulmonology, Department of Medicine, University of Cape Town Lung Institute, Cape Town, South Africa
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlvar AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authors
- Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)By Roland Buhl, François Maltais, Roger Abrahams, Leif Bjermer, Eric Derom, Gary Ferguson, Matjaž Fležar, Jacques Hébert, Lorcan McGarvey, Emilio Pizzichini, Jim Reid, Antony Veale, Lars Grönke, Alan Hamilton, Lawrence Korducki, Kay Tetzlaff, Stella Waitere-Wijker, Henrik Watz and Eric BatemanRoland Buhl1Pulmonary Department, Mainz University Hospital, Mainz, GermanyFrançois Maltais2Département de Médecine, Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaRoger Abrahams3Department of Clinical Research, Morgantown Pulmonary Associates, Morgantown, WV, USALeif Bjermer4Department of Respiratory Medicine and Allergology, Lund University, Lund, SwedenEric Derom5Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumGary Ferguson6Pulmonary Research Institute of Southeast Michigan, Livonia, MI, USAMatjaž Fležar7Klinika Golnik, Golnik, SloveniaJacques Hébert8Department of Medicine, Centre de Recherche Appliquée en Allergie de Québec (CRAAQ), Québec, CanadaLorcan McGarvey9Department of Medicine, Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UKEmilio Pizzichini10Department of Pulmonology, NUPAIVA (Asthma Research Centre), Universidade Federal de Santa Catarina, Santa Catarina, BrazilJim Reid11Dunedin School of Medicine, University of Otago, Dunedin, New ZealandAntony Veale12Department of Respiratory Medicine, The Queen Elizabeth Hospital, Adelaide, AustraliaLars Grönke13Department of Medical Affairs Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyAlan Hamilton14Medical Department, Boehringer Ingelheim, Burlington, Ontario, CanadaLawrence Korducki15Department of Biostatistics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAKay Tetzlaff13Department of Medical Affairs Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany16Department of Sports Medicine, Medical Clinic V, University of Tübingen, Tübingen, GermanyStella Waitere-Wijker17Medical Department, Boehringer Ingelheim B.V., Alkmaar, The NetherlandsHenrik Watz18Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research, Grosshansdorf, GermanyEric Bateman19Division of Pulmonology, Department of Medicine, University of Cape Town Lung Institute, Cape Town, South Africa
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar A. Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlvar A. AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section
- Home-based telerehabilitation program using real-time monitoring and interactive exercise for patient with lung cancer: A feasibility studyBy Valerie Coats, Hélène Moffet, Sébastien Simard, Lise Tremblay, Lynda Fradette, François Maltais and Didier SaeyValerie Coats1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaHélène Moffet2Rehabilitation, Université Laval, Québec, Canada3CIRRIS Research Center, Quebec Rehabilitation Institute, Québec, CanadaSébastien Simard1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaLise Tremblay1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada4Medicine, Université Laval, Québec, CanadaLynda Fradette5Clinique d'Oncologie Thoracique, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaFrançois Maltais1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada4Medicine, Université Laval, Québec, CanadaDidier Saey1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada2Rehabilitation, Université Laval, Québec, Canada
- Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patientsBy Sally Singh, Francois Maltais, Lee Tombs, Alison Church, Ahmar Iqbal and John H. RileySally Singh1Centre for Exercise and Rehabilitation Science, University Hospitals of Leicester NHS Trust, Leicester, United KingdomFrancois Maltais2Centre de Pneumologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Sainte-Foy, CanadaLee Tombs3Respiratory Medicines Development Centre, GlaxoSmithKline, Stockley Park, United KingdomAlison Church4Respiratory and Immuno-Inflammation, GlaxoSmithKline, Research Triangle Park, United StatesAhmar Iqbal4Respiratory and Immuno-Inflammation, GlaxoSmithKline, Research Triangle Park, United StatesJohn H. Riley3Respiratory Medicines Development Centre, GlaxoSmithKline, Stockley Park, United Kingdom
- Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockersBy Eric Derom, Stephanie Korn, Alan Hamilton, Valeria C. Amatto, Yihua Zhao and François MaltaisEric Derom1Department of Internal Medicine, Ghent University Hospital, Ghent, BelgiumStephanie Korn2University Medical Center, Johannes Gutenberg University, Mainz, GermanyAlan Hamilton3Clinical Development Department, Boehringer Ingelheim, Burlington, CanadaValeria C. Amatto4Medical Affairs Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyYihua Zhao5Statistics Department, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT United StatesFrançois Maltais6Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada
- Mid-thigh cross-sectional area and lower limb muscle function in patients with lung cancerBy Valerie Coats, Fernanda Ribeiro, Lise Tremblay, Brigitte Fortin, François Maltais and Didier SaeyValerie Coats1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaFernanda Ribeiro1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaLise Tremblay1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada3Medicine, Université Laval, Québec, CanadaBrigitte Fortin1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, CanadaFrançois Maltais1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada3Medicine, Université Laval, Québec, CanadaDidier Saey1Pneumology, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada2Rehabilitation, Université Laval, Québec, Canada
- Acute physiological effects of partitioning exercise on exercise workload and quadriceps fatigue during resistance exercise in COPDBy André Nyberg, Didier Saey, Mickaël Martin and François MaltaisAndré Nyberg1Pneumologie, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Québec, CanadaDidier Saey1Pneumologie, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Québec, Canada2Département de Réadaptation, Faculté de Médecine, Université Laval, Québec, CanadaMickaël Martin1Pneumologie, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Québec, CanadaFrançois Maltais1Pneumologie, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Québec, Canada3Département de Médecine, Faculté de Médecine, Université Laval, Québec, Canada
- Exertional dyspnea relief following bronchodilation in COPD: Role of neural respiratory driveBy Courtney Wilkinson-Maitland, Benoit Borel, Helene Perrault, Alan Hamilton, Jean Bourbeau, Francois Maltais and Dennis JensenCourtney Wilkinson-Maitland1Kinesiology & Physical Education, McGill University, Montreal, QC CanadaBenoit Borel2Institut Universitaire de Cardiologie et Pneumologie du Quebec, Université de Laval, Quebec, QC CanadaHelene Perrault3Faculty of Health Sciences, University of Ottawa, Ottawa, ON CanadaAlan Hamilton4Medical Department, Boehringer Ingelheim (Canada) Ltd., Burlington, ON CanadaJean Bourbeau1Kinesiology & Physical Education, McGill University, Montreal, QC CanadaFrancois Maltais2Institut Universitaire de Cardiologie et Pneumologie du Quebec, Université de Laval, Quebec, QC CanadaDennis Jensen1Kinesiology & Physical Education, McGill University, Montreal, QC Canada
- LATE-BREAKING ABSTRACT: Oxygen titration and weaning with FreeO2 in COPD patients hospitalized for exacerbation. A randomized controlled pilot studyBy François Lellouche, Pierre-Alexandre Bouchard, Maude Roberge, Guillaume Babin, François Maltais, Yves Lacasse and Erwan L'HerFrançois Lellouche1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC CanadaPierre-Alexandre Bouchard1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC CanadaMaude Roberge1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC CanadaGuillaume Babin1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC CanadaFrançois Maltais1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC CanadaYves Lacasse1Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC CanadaErwan L'Her2LATIM, INSERM UMR 1101, Université de Bretagne Occidentale, Brest, France
- Use of exercise testing in the evaluation of interventional efficacy: an official ERS statementBy Luis Puente-Maestu, Paolo Palange, Richard Casaburi, Pierantonio Laveneziana, François Maltais, J. Alberto Neder, Denis E. O'Donnell, Paolo Onorati, Janos Porszasz, Roberto Rabinovich, Harry B. Rossiter, Sally Singh, Thierry Troosters and Susan WardArticle | Published in 2016 in European Respiratory JournalLuis Puente-Maestu1Servicio de Neumología del Hospital Universitario Gregorio Marañón, Madrid, Spain2Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain3Facultad de Medicina de la Universidad Complutense de Madrid, Madrid, SpainPaolo Palange4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, ItalyRichard Casaburi5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USAPierantonio Laveneziana6UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Universités, UPMC Université Paris 06, INSERM, Paris, France7Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, FranceFrançois Maltais8Institut Universitaire Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, CanadaJ. Alberto Neder9Laboratory of Clinical Exercise Physiology, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, Canada10Division of Respirology, Clinical Exercise Physiology Unit, Federal University of Sao Paulo, Sao Paulo, BrazilDenis E. O'Donnell11Respiratory Investigation Unit, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, CanadaPaolo Onorati4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, Italy12Ospedale Civile di Alghero, ASL1-Sassari, Alghero (SS), ItalyJanos Porszasz5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USARoberto Rabinovich13ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen`s Medical Research Institute, University of Edinburgh, Edinburgh, UKHarry B. Rossiter5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA14Faculty of Biological Sciences, University of Leeds, Leeds, UKSally Singh15Centre for Exercise and Rehabilitation Science, Glenfield Hospital, University Hospitals of Leciester NHS Trust, Leciester, UKThierry Troosters16Dept of Rehabilitation Sciences, KU Leuven, Leuven, Belgium17Respiratory Rehabilitation Division, University Hospital Gasthuisberg, Leuven, BelgiumSusan Ward18Human Bio-Energetics Research Centre, Crickhowell, UK
- Use of exercise testing in the evaluation of interventional efficacy: an official ERS statementBy Luis Puente-Maestu, Paolo Palange, Richard Casaburi, Pierantonio Laveneziana, François Maltais, J. Alberto Neder, Denis E. O'Donnell, Paolo Onorati, Janos Porszasz, Roberto Rabinovich, Harry B. Rossiter, Sally Singh, Thierry Troosters and Susan WardLuis Puente-Maestu1Servicio de Neumología del Hospital Universitario Gregorio Marañón, Madrid, Spain2Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain3Facultad de Medicina de la Universidad Complutense de Madrid, Madrid, SpainPaolo Palange4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, ItalyRichard Casaburi5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USAPierantonio Laveneziana6UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Universités, UPMC Université Paris 06, INSERM, Paris, France7Service des Explorations Fonctionnelles de la Respiration, de l'Exercice et de la Dyspnée, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, FranceFrançois Maltais8Institut Universitaire Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, CanadaJ. Alberto Neder9Laboratory of Clinical Exercise Physiology, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, Canada10Division of Respirology, Clinical Exercise Physiology Unit, Federal University of Sao Paulo, Sao Paulo, BrazilDenis E. O'Donnell11Respiratory Investigation Unit, Division of Respiratory and Critical Care Medicine, Queen's University and Kingston General Hospital, Kingston, ON, CanadaPaolo Onorati4Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, Rome, Italy12Ospedale Civile di Alghero, ASL1-Sassari, Alghero (SS), ItalyJanos Porszasz5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USARoberto Rabinovich13ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen`s Medical Research Institute, University of Edinburgh, Edinburgh, UKHarry B. Rossiter5Rehabilitation Clinical Trials Center, Division of Pulmonary and Critical Care Physiology and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA14Faculty of Biological Sciences, University of Leeds, Leeds, UKSally Singh15Centre for Exercise and Rehabilitation Science, Glenfield Hospital, University Hospitals of Leciester NHS Trust, Leciester, UKThierry Troosters16Dept of Rehabilitation Sciences, KU Leuven, Leuven, Belgium17Respiratory Rehabilitation Division, University Hospital Gasthuisberg, Leuven, BelgiumSusan Ward18Human Bio-Energetics Research Centre, Crickhowell, UK
- Cardiovascular Complications of Respiratory DisordersEdited by Miguel Ángel Martínez-García, Jean-Louis Pépin and Mario CazzolaBook | Published in 2020DOI: 10.1183/2312508X.erm8820ISBN (electronic): 978-1-84984-119-1Miguel Ángel Martínez-GarcíaJean-Louis Pépin
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.